Inhibiting Ribosomal RNA Synthesis in C. elegans Protects Against Reductive Stress During de novo Fatty Acid Synthesis Deficiency

Clicks: 6
ID: 324642
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #72 of 317 articles by views in current genetics

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 317 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Reductive stress has remained underappreciated as a significant disrupter of redox homeostasis. Recent studies have begun to link the accumulation of NADH and NADPH to the development and progression of metabolic diseases such as cancer, cardiac disease, and diabetes. In this study we use the nematode Caenorhabditis elegans to examine the phenomenon of catastrophic reductive-death caused by combined biguanide treatment and fasn-1 deficiency. This process of synergistic biguanide-induced reductive stress correlates with the activation of hypodermal stress response genes and aberrant alternations in the nucleolar morphology of hypodermal cells. Interestingly, we find that loss-of-function and RNAi-based knockdown of the catalytic RNA exosome subunit crn-3 significantly protects against reductive death. RNAi knockdown of multiple other genes involved in rRNA synthesis recapitulate this phenotype. We postulate that this reversal of reductive death can be attributed to impaired ribosomal RNA biogenesis that promotes tolerance of accumulated reducing equivalents NADPH and NADH while also preventing the accumulation of GSH by potentially activating downstream signaling pathways. Notably, we identify a downstream nuclear RNAi pathway that is activated by phenformin in a fasn-1 dependent manner and is also activated upon disruption of rRNA processing. Overall, we identify a novel mechanism by which pathologic states of reductive stress-related diseases could be ameliorated.
Reference Key
openalex_W7202192628 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jen F. Rotti, Fasih M. Ahsan, Nicole L. Stuhr, Sinclair Emans, Alexander Soukas, Armen Yerevanian
Journal current genetics
Year 2026
DOI
10.1093/genetics/iyag214
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.